A Multicenter, Randomized, Double-Blind Study of the Effects of Aripiprazole in Overweight Subjects With Schizophrenia or Schizoaffective Disorder Switched From Olanzapine
Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.4088/jcp.v69n0702
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: aripiprazole, olanzapine, schizophrenia, schizoaffective disorder, overweight, antipsychotic switching, weight change, triglycerides, total cholesterol, HDL cholesterol, glycemic control, metabolic risk, cardiovascular risk, weight gain, weight loss, antipsychotic adverse effects, treatment discontinuation
Open Access status: closed
OpenAlex ID: W1994877202
